Skip to main content
. 2017 Jul 31;38(33):2547–2555. doi: 10.1093/eurheartj/ehx352

Table 4.

Myocardial perfusion reserve and Lp(a) levels of the AdVEGF-DdNdC treated patients

Baseline 3 months 12 months P-value
Lp (a) tertiles 3rd 2nd 1st 3rd 2nd 1st 3rd 2nd 1st
n = 5 n = 5 n = 5 n = 5 n = 5 n = 4 n = 5 n = 5 n = 5
Lp(a) mg/dL 52.7 ± 13.3 11.8 ± 6.4 3.8 ± 2.0 53.9 ± 20.5 11.0 ± 5.0 3.2 ± 1.3 59.1 ± 19.6 13.8 ± 4.1 3.3 ± 0.7 0.023
Treated area MPR 0.94 ± 0.32 1.16 ± 0.45 1.03 ± 0.34 1.43 ± 0.45 1.39 ± 0.57 1.17 ± 0.38 1.76 ± 0.41 1.42 ± 0.53 1.22 ± 0. 0.089

Mean ± SD. Tertiles refer to Lp(a) at baseline. P-value for interaction time x tertiles. P-values for all comparisons in Supplementary material online, Table S2.

MPR, myocardial perfusion reserve; SD, standard deviation; Lp(a), lipoprotein(a).